Caveolae (small plasma membrane invaginations) and their coat proteins, caveolins, have attracted the attention of researchers in diverse fields, including cell biology, cardiovascular and cancer research. The tight association between caveolin and cholesterol governs the biochemical behaviour of caveolae and is emerging as an important characteristic in a number of processes assigned to these multifunctional organelles. In this review, selected aspects of the caveolin-cholesterol association and its potential functional implications are discussed.
binding antibiotics, such as filipin and nystatin, flatten caveolae [6] . Caveolin was found to bind tightly to cholesterol, with at least 1 mol of cholesterol remaining associated per mol of caveolin in the presence of 0.2% SDS [10] . Furthermore, caveolin was found to be one of the most abundant proteins cross-linked to a photo-activatable cholesterol analogue [11] . The N-and C-termini of the protein face the cytoplasm [12] with an intervening 33-amino-acid hydrophobic segment predicted to reside within the membrane. The C-terminus of caveolin is also attached to the lipid bilayer by three palmitoyl residues.
Caveolae behave biochemically as highly detergentinsoluble membranes of low buoyant density and hence will become co-isolated with other low-density, detergent-resistant cellular membranes (DRMs), unless additional purification steps are taken. In addition to cholesterol, DRMs are typically enriched in sphingolipids, and caveolae also harbour sphingolipids. However, caveolae were reported to contain more cholesterol (relative to sphingolipids) as compared with other types of DRMs [13, 14] . Interestingly, the distribution of sphingolipids between caveolae and other plasma membrane domains appears to be regulated, e.g. by their differential internalization rates in caveolar compared with non-caveolar plasma membranes [15] .
Caveolin-cholesterol association and signalling
The precise topology of caveolin in relation to caveolar lipids remains an open question. The membrane-embedded amino acids should be important for determining the affinity of the molecule with DRMs, but specific regions responsible for this association have not been assigned. In addition, the scaffolding domain (amino acids 82-101 of caveolin-1) immediately adjacent to the membrane insertion site may be important. In a model membrane, a scaffolding domain peptide induced the formation of domains enriched in cholesterol and acidic phospholipids [16] . Moreover, the Src kinase membrane-binding region was co-localized in such domains. The scaffolding domain is thought to be important for caveolin oligomerization, as well as for caveolin interaction with other proteins. In a study addressing caveolin oligomerization, a peptide comprising amino acids 79-96 of caveolin was shown to form α-helical heptameric subunits. These units were suggested to constitute the core of the filamentous caveolin coat [17] . Whether all of these functions are indeed assigned to this domain, or whether some of the interactions seen in vitro could be related to its tendency to interact non-specifically with membranes, remains an open question [18] .
The scaffolding domain of caveolin-1 has been reported to interact with and negatively regulate a number of signalling molecules, such as c-Src [19] and eNOS (endothelial nitric oxide synthase) [20] . The importance of the caveolin-eNOS interaction was convincingly demonstrated in vivo in caveolin-1-deficient mice. The mice exhibit problems in the control of vasodilatation/constriction due to constitutive eNOS activation [21] . Roy et al. [22] showed that H-Ras-induced Raf activation was compromised upon expression of a dominantnegative mutant of caveolin (cav-dn), which is a caveolin N-terminal truncation mutant that still contains an intact scaffolding domain. cav-dn expression results in the depletion of plasma membrane caveolae (see below). Importantly, the effect of cav-dn on signalling was shown to be mediated by cholesterol, since the replenishment of cholesterol reversed the inhibition.
Caveolins and cholesterol trafficking
Caveolae/caveolins have been proposed to function in a number of cholesterol-trafficking steps, including cholesterol efflux, selective cholesterol uptake and the delivery of newly synthesized cholesterol to the plasma membrane. Conclusive evidence for caveolin involvement in these processes is at present lacking. The data presented remain controversial, partly due to the different cell systems used and the different analytical procedures followed. The potential involvement of caveolins in cholesterol efflux and biosynthetic cholesterol delivery will be briefly discussed below. Studies addressing the potential role of caveolae in scavenger receptor-B1 (SR-B1)-mediated selective cholesterol uptake have recently been summarized [23] .
Cholesterol efflux to apolipoprotein A-I (apoA-I) or high-density lipoprotein (HDL)
Cholesterol efflux takes place from different membrane regions, and via different mechanisms, depending on the type of acceptor used. Efflux via the ATP-binding cassette transporter A1 (ABCA1) is physiologically significant, as demonstrated by the intracellular accumulation of cholesterol and defective reverse cholesterol transport (from the peripheral cells to the liver for excretion) in patients with ABCA1 mutations [24] . ApoA-I serves as an extracellular acceptor for the efflux of lipids via this route. The membrane environment of ABCA1 is, however, solubilized by detergents under conditions in which caveolin remains resistant to solubilization [25] . This suggests that caveolin and ABCA1 partition into different domains, and rather argues against a role for caveolae in ABCA1-dependent cholesterol efflux.
Cholesterol efflux to HDLs, small HDL particles such as HDL3 and pre-β-HDL in particular, appears to be mediated from cholesterol-based domains distinct from those functioning in apoA-I/ABCA1-dependent cholesterol efflux [26] . There is evidence suggesting that cholesterol efflux to pre-β-HDL particles takes place in caveolae [27] . In accordance with this, HDL and caveolin-1 were found to co-localize in caveolae by immunoelectron microscopy in cholesterolloaded endothelial cells [28] .
We found that overexpression of caveolin-1 via the Semliki Forest virus system led to enhanced delivery of radiolabelled [ 14 C]cholesterol to serum acceptors from BHK cells (S. Heino and E. Ikonen, unpublished work). HDL represents a major cholesterol acceptor under such conditions [29] . Moreover, expression of cav-dn was accompanied by a reduction in the number of plasma membrane caveolae, as well as a reduced efflux of radiolabelled cholesterol to serum [30] . Cellular cholesterol levels were, however, not significantly elevated, potentially due to the parallel reduction in cholesterol biosynthesis. cav-dn protein itself was not targeted to the plasma membrane, but was associated with the surface of lipid droplets.
Delivery of newly synthesized cholesterol to the plasma membrane
Caveolin has been reported to transport newly synthesized cholesterol from the ER (endoplasmic reticulum) to plasma membrane caveolae [31, 32] . This transport was found to be rapid, to involve a cytosolic complex of caveolin, cholesterol and chaperones, and to be pharmacologically inhibited by rapamycin or cyclosporin A. The mechanism would thus be different from the rapid vesicular transport process characterized in a previous study [33] . It is also different from the system involved in the efflux of newly synthesized cholesterol to cyclodextrin, because this process was found to be cyclosporin A-resistant [34] . In addition to cell-type differences, a potential source of the differential findings may be the resolution of sterols.
An inherent problem in analysing nascent cholesterol transport is that, in most cells, the rate of cholesterol transfer from the ER to the plasma membrane is considerably higher than the rate of cholesterol synthesis [34] . This leads to a situation in which a number of cholesterol precursor sterols are present in cells at the time when the first newly synthesized cholesterol molecules reach the cell surface and extracellular acceptors. Furthermore, cholesterol precursors such as zymosterol, lathosterol and desmosterol reach the plasma membrane rapidly, and their efflux from cells occurs more readily than that of cholesterol itself [29] . Thus pooling sterol transport data may lead to an overestimation of the cholesterol transport rate. This reinforces the necessity to identify individual sterol species.
We found caveolin overexpression to stimulate the efflux of pre-existing cholesterol from BHK cells to serum (see above). Surprisingly, the release of [ 3 H]acetate pulse-labelled, newly synthesized cholesterol from these cells under the same conditions was not altered (S. Lusa and E. Ikonen, unpublished work). This suggests that newly synthesized cholesterol is a less favoured target than pre-existing (most likely plasma membrane or endosomal) cholesterol for caveolin-mediated cholesterol efflux. Evidently, caveolae and caveolins are not required for plasma membrane delivery of cholesterol in hepatic cells that synthesize and transport cholesterol efficiently [29, 34] , yet which lack caveolae and do not have detectable levels of caveolin [35] .
Summary and conclusions
The binding of the caveolar coat protein caveolin to cholesterol is critical for the maintenance of the caveola structure and for the functionality of caveolae. The best-characterized effects of perturbing caveolae are linked to cell signalling. This applies both to cell-culture conditions and to the situation in vivo in caveolin-1-deficient mice. Direct roles of caveolins/caveolae as net transporters of cholesterol between subcellular compartments, and in the exchange of cholesterol with lipoproteins, remain less conclusive, and await detailed studies utilizing caveolin-deficient mice. The transport of newly synthesized cholesterol from the ER to the plasma membrane does not require caveolae, as evidenced by the effective trafficking of nascent cholesterol in hepatic cells lacking caveolae. This is in accordance with the presumably subtle alterations in lipid trafficking in the knock-out mice. However, intracellular cholesterol redistribution is induced upon disruption of caveolin trafficking and perturbation of caveolae by expression of the cav-dn protein. Targeting of cav-dn to lipid droplets points to a potential new role of caveolins in the process of lipid-droplet formation, and will undoubtedly stimulate research on the relationship between caveolin, cholesterol and lipid-droplet biogenesis.
